Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date.
First Quarter 2025 Conference Call Details
Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT
Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer
Webcast Link: https://edge.media-server.com/mmc/p/q53hzimg
Dial-In Link: https://register-conf.media-server.com/register/BI52d4ebca7736415daa72f2a62f1d61ce
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
The call may also be accessed through the company's investor relations website, at https://ir.solesence.com/. Please join the conference call at least five minutes before prior to the start time.
About Solésence, Inc.
Solésence, Inc. (NASDAQ:SLSN) is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.
Media Contact:
Investor Relations Contact:
